Tailfifty desk
424,069 observationssnapshot 2026-10-15Registry

Sports · 1d · asked 2026-10-11 · scored 2026-10-12

Will the Atlanta Falcons beat the Baltimore Ravens at home on October 12, 2026?

4 seats worked this question alone; the panel agreed within a few points, so no debate was run. Code ran every test and computed the number. How the desk works

Committee37%logodds poolLog-odds pool How the committee number is made: each seat's probability is turned into log-odds, averaged with calibration weights, and turned back. Deterministic. The portfolio manager explains it; it does not pick it. glossary · PM stated 36%
Market at the time62%committee minus market −24%
ResolvedNoBrierBrier score How wrong a probability was, squared. Say 70% and it happens: (0.7 − 1)² = 0.09. Say 70% and it doesn't: 0.49. Lower is better; always saying 50% scores 0.25, so anything above 0.25 is worse than a coin flip. glossary 0.138 vs marketMarket Brier The same squared error, but for the Kalshi price at the moment the question was asked. It is the bar: beating it means knowing something the price did not. glossary 0.378 · lower is better

Judged by Kalshi KXNFLGAME-26OCT11BALATL-ATL settlement at 2026-10-12: Kalshi KXNFLGAME-26OCT11BALATL-ATL: resolves YES if Atlanta Falcons win

0%50%100%
Sports Analyst37%
Quantitative Researcher39%
Market Positioning Analyst39%
Causal Skeptic34%
Committee37%

Hollow: before the debate. Gold: after. Blue rule: the market. Red rule: what happened. Debate skipped: the seats agreed within a few points. Sat out: Historical Analog Analyst.

The dispute that matteredCausal Skeptic (D, P=0.34) vs. the other three (P=0.37-0.39): D argues that the market-implied probability, while the only information-rich input, is a price reflecting unknown private information (injuries) rather than a validated causal signal, and that every other statistical test in the pool (regime splits, OLS on home-field, conditional win-rate comparisons) failed to reject the null — implying the committee has very little independent, mechanism-level evidence and should not over-trust the price's precision. A/B/C treat the converged 0.385 market print as close to the best available point estimate because it already impounds the late injury/news shock (d7/d8 spike) that no fundamental series captures. Resolution: I side with treating the market price as the dominant anchor (it is the freshest, most information-dense input and the injury-timing story is coherent) but shade the consensus below the raw 0.385 print toward 0.36, both because d2/d4/d5/d8 are not four independent confirmations (they are 1-2 underlying quote series resampled, per Analyst C's autocorrelation finding) and because D is correct that none of the fundamental causal claims survive scrutiny, so there is no second independent line of evidence to push probability back up toward the 0.55-0.57 generic home-field base rate.

Synthesis

Base rate: generic NFL home win rate ~0.55-0.57 (cited, not re-derived). The panel unanimously updates well below this base rate, to 0.34-0.39, anchored almost entirely on a market-implied probability series that has drifted from 0.635 to 0.385 over the week, reinforced by BAL's statistically positive point-differential (CI excludes zero) and a late injury/news-volume spike. Critically, the four 'confirming' market series (d2, d4, d5, d8) are not independent — lag-1 autocorrelation of 0.997 and cross-correlation of 0.97 show this is largely one slow-moving quote sampled multiple times, so I collapse them into a single line of evidence rather than four. Every fundamental causal/statistical test run by the Causal Skeptic (home-field OLS, regime splits, conditional win-rate comparisons) was null or regime-dependent, meaning the panel has essentially no validated mechanism-level evidence beyond the price itself and BAL's margin advantage.\n\nConsensus: 0.36, CI [0.29, 0.43] — slightly below the deterministic pool (0.37) and below the raw market print (0.385), reflecting (a) treating the duplicated market series as one evidence line rather than several, and (b) crediting the Causal Skeptic's best-in-segment calibration and valid point that no causal signal survived testing, which argues for added caution rather than full trust in the price's precision.\n\nTradeability: NOT tradeable as a standalone edge. The committee's consensus (0.36) and the market's own implied price (0.385) differ by only ~2.5 points, well within the stated CI and almost certainly within typical sportsbook vig/spread. No analyst identified a mispricing the committee can exploit independently of the market itself — the market has already moved from 0.635 to 0.385 ahead of this analysis, i.e., it got there first. If a counterparty is offering ATL win probability meaningfully above 0.40-0.42 (e.g., due to stale pricing), a small fade (short ATL / long BAL) would be consistent with this view; absent that gap, no position is justified given high crowding (0.85) and weak statistical quality (0.45) in the underlying signal set.\n\nTop disagreement: Causal Skeptic (0.34) vs. others (0.37-0.39) on how much trust to place in the market price given that it's a price, not a causal signal, and the duplicated-series problem. Resolved by anchoring on the price as the best available point estimate (it's the freshest, most information-dense input and is consistent with a coherent injury-timing story) while shading down from the raw print to account for the duplication and the lack of any independent corroborating causal evidence.
Observed · in the data
  • Market-implied ATL win probability has drifted from a season median of ~0.635 down to a repeated terminal value of 0.385 as of 2026-10-11 (game eve), across at least two sampled series (d2, d4).
  • BAL's 7-game point-differential series: mean +12.14, most recent values 18, -7, 3, 6.
  • BAL win rate over last 7 games: mean 0.857 vs ATL's 0.571 (d3/d4).
  • An injury/news-count proxy series jumped sharply (0-1 to 2, and 1 to 5) in the final 2-3 days before the game, coincident with the drop in market-implied ATL probability.
  • Lag-1 autocorrelation of 0.997 and cross-series correlation of 0.97 between d2 and d4, indicating these are largely the same slow-moving quote, not independent confirmations.
  • Generic NFL home-team win base rate cited by two analysts as ~0.55-0.57 (not re-derived here from a fresh backtest).
Modeled · a tool computed it
  • Calibration-weighted log-odds pooling of the four analysts' post-debate probabilities, producing the deterministic committee number of 0.37.
  • Bootstrap confidence interval on BAL's point-differential series (s7).
  • Autocorrelation/cross-correlation diagnostics on d2 vs d4 (s5) used to detect duplicated evidence.
Inferred · the committee's reasoning
  • The late injury/news spike (d7/d8) is the proximate cause of the market's repricing of ATL downward from ~0.635 to ~0.385 (plausible causal story, not directly verified against a named player/event in this evidence set).
  • The market price is closer to 'informationally efficient' than any fundamental series examined, because every tested causal/statistical signal (home-field OLS, regime splits, conditional win-rate tests) failed to reject the null at p<0.05.
  • BAL's positive point-differential (bootstrap CI [3.02, 12.17], excludes zero) supports BAL being the genuinely stronger team by scoring margin this season, independent of the market price.
Predicted · what it expects
  • P(ATL beats BAL at home on 2026-10-12) ≈ 0.36, 90%-ish CI [0.29, 0.43], essentially flat from the panel's pre-debate priors (unanimous within 0.05) and modestly below the raw market print of 0.385.
  • Expected value of the ATL-win indicator variable over the 1-day horizon ≈ 0.36.
Uncertain · what it does not know
  • Whether the generic ~0.55-0.57 home-field base rate has any residual relevance here, or whether it is fully superseded by the market price — the panel's causal tests cannot distinguish confounding/non-stationarity from a real but small home-field effect (s4 regime sign-flip).
  • The specific nature/validity of the injury or news event implied by the d7/d8 spike — not independently confirmed by a named injury report in the evidence provided.
  • Whether d5's 'market-implied probability' and d2/d4's series are drawn from the same underlying betting market or different proxies, which affects how much independent weight they deserve.
  • Model uncertainty: all four analysts' calibration in this exact segment is weak-to-moderate (accuracy 28.6%-36%, brier 0.28-0.305 vs. a naive 0.25 for a 50/50 coin at these base rates), so the stated confidence intervals likely understate true uncertainty.
How the seats were weighed · not an average
Quantitative Researcher0.30Best combination of rigor and relevance: explicit bootstrap CI on BAL margin excluding zero, identifies the injury/news shock timing (d7/d8) that explains the price move, decent calibration (brier 0.284, n=25). Treated as primary anchor for the market-based estimate.
Market Positioning Analyst0.27High relevance and the only analyst who explicitly diagnosed that d2/d4 are near-duplicate samples of the same slow-moving quote (corr 0.97, lag-1 autocorr 0.997) rather than independent confirmation — credited for correctly deflating the weight of 'two series agreeing.' Calibration accuracy modest (32%).
Sports Analyst0.20Highest raw domain relevance to sports (1.0) and supplies the only team-level fundamental context (recent margin/win-rate trends), but worst calibration in-segment (accuracy 28.6%, brier 0.305), so down-weighted relative to stated relevance.
Causal Skeptic0.23Best calibration of the four (brier 0.281) and the only one who stress-tested the statistical claims (regime-dependent sign flips, null hypothesis tests) — valuable as a check against overfitting the market price into a 'causal' story, even though its own point estimate still just re-anchors on the same market price.
Wrong if
  • If Atlanta wins the game on 2026-10-12, this forecast (P=0.36) is falsified in the sense that the low-probability outcome occurred; track whether realized outcomes across a larger sample of similar pooled forecasts are well-calibrated (e.g., ATL-style underdogs priced 0.30-0.40 should win 30-40% of the time over a multi-game sample).
  • If the market-implied probability for ATL moves materially (e.g., back above 0.45) between 2026-10-11 11:42 UTC and kickoff on 2026-10-12, that would falsify the 'market has already fully priced the injury/news shock' sub-thesis underlying the consensus anchor.
  • If a post-game review shows no material injury/news event for either team in the 48 hours before kickoff, that falsifies the d7/d8 injury-shock causal story used to justify trusting the price move.

The seats

Each analyst's own memo, evidence and tests. Open a seat to read it.

Sports Analyst37%confidence 35%

Objective: translate sporting information into win probabilities and compare them to betting-market prices. Injuries (who, position, replacement quality), rest and schedule, home advantage, form vs. noise, and how fast lines move after news. You care about the *market reaction function*: which news the line absorbs in minutes and which it underreacts to. A 60% team is only interesting if the market says 52%. Discipline: state the prediction cutoff (kickoff) and use nothing after it. Team series live under NFL-<ABBR> (margin, win, is_home, points_for/against, espn_spread, espn_total, kalshi_win_prob, injuries_out, injuries_questionable). Estimate team effects with partial pooling and report uncertainty, not point claims. Model dispersion as well as the mean. Beat a simple baseline (home field + the market line) out of sample before believing any feature. Injury counts are a proxy for who is missing; say so.

Thesis. Baltimore is the stronger team by recent point differential and win rate, but Atlanta gets home field and enters on a two-game double-digit-margin run; fair value for ATL sits close to, slightly below, the market's current ~38.5% implied price.
Base rate

39% NFL home teams win roughly 57% of games historically, but the market-implied price for this specific game (0.385) already reflects BAL being favored on the road, making it a tighter, more relevant base rate than the generic home-field number.

The best case against

ATL's last two games show +21 margins each (d1 last values), a hot recent streak that a simple 7-game mean or win-rate baseline underweights; if that form is signal rather than noise (sd=22.6 on d1 is very large relative to the mean), ATL's true win probability could be meaningfully above both my estimate and the market's 38.5%, especially combined with home field.

Strongest evidence
  • Most recent, as-of-date (2026-10-11) win-probability readings cluster tightly at 0.385 for ATL, the freshest market signal available before kickoff.
  • BAL's 7-game margin series (mean +12.14, last values 18, -7, 3, 6) shows a strong but cooling team, still net positive.
  • BAL win rate over last 7 games (mean 0.857) is much higher than ATL's (d3 mean 0.571), supporting BAL as the true favorite.
Wrong if

If the Falcons actually win the 2026-10-12 game (Kalshi KXNFLGAME-26OCT11BALATL-ATL settles YES), this thesis's directional lean toward BAL is falsified; alternatively, if a pre-kickoff inactive-list check shows a key BAL starter ruled out and the market-implied ATL probability moves materially above 0.45 before kickoff, the 'no edge vs. market' claim is falsified.

Assumes
  • d8's most recent cluster of readings (all 0.385, dated 2026-10-11) represents the current market-implied probability for ATL winning this specific game.
  • d1 and d2 are ATL's and BAL's respective 7-game scoring-margin histories; d3/d4 are their corresponding win/loss flags over the same window.
  • d5/d6 (injuries_out, injuries_questionable) reflect a standard weekly injury-report escalation into game week for one of the two teams; without team attribution I cannot assign directional edge from this series.
  • No information after 2026-10-11 11:42 UTC is used; final inactives and weather for the 2026-10-12 kickoff are unknown.
Memo to the committee
Base rate for this matchup is best anchored to the market price (38.5%, d8) rather than the generic NFL home-field rate (~57%), since the market already incorporates BAL being favored on the road. Team-strength series (d1-d4) confirm BAL as the stronger team over the last 7 games on both margin and win rate, consistent with BAL being favored despite playing away. ATL's two-game hot stretch is real but sits inside a very high-variance series (sd=22.6), so I don't treat it as strong momentum evidence. Rising injury counts (d5/d6) into game week add genuine uncertainty but cannot be attributed to either team from the data given, so I hold them as a wash. Net: I land at 37% for ATL, essentially aligned with the market's 38.5% — this is a 'no strong edge vs. market' call rather than a contrarian bet, reflecting genuine uncertainty rather than conviction either way.
Rebuttal
debate skipped: panel unanimous within 0.05

Would change my mind: If the Falcons actually win the 2026-10-12 game (Kalshi KXNFLGAME-26OCT11BALATL-ATL settles YES), this thesis's directional lean toward BAL is falsified; alternatively, if a pre-kickoff inactive-list check shows a key BAL starter ruled out and the market-implied ATL probability moves materially above 0.45 before kickoff, the 'no edge vs. market' claim is falsified.

After the debate · 37% → 37%

debate skipped: panel unanimous within 0.05

Data and tests · 14, as of
Quantitative Researcher39%confidence 40%

Loading…

Market Positioning Analyst39%confidence 50%

Loading…

Causal Skeptic34%confidence 30%

Loading…

Claims and evidence

Observation · seen in the data · 7
Model · a tool computed it · 3
Inference · reasoned from the above · 7
Forecast · what a seat expects · 2
Uncertainty · what a seat does not know · 2

The debate

Who challenged whom · severity 0 to 1
SportsQuantiMarketCausal
Sports
Quantitative
Market Posit
Causal Skept
Sealed views · Each seat wrote alone. Nobody had seen another view.
Sports Analyst
37% · confidence 35%

Baltimore is the stronger team by recent point differential and win rate, but Atlanta gets home field and enters on a two-game double-digit-margin run; fair value for ATL sits close to, slightly below, the market's current ~38.5% implied price.

Own objection: ATL's last two games show +21 margins each (d1 last values), a hot recent streak that a simple 7-game mean or win-rate baseline underweights; if that form is signal rather than noise (sd=22.6 on d1 is very large relative to the mean), ATL's true win probability could be meaningfully above both my estimate and the market's 38.5%, especially combined with home field.

Quantitative Researcher
39% · confidence 40%

Base rate for NFL home teams winning is ~57%, but this specific matchup has team-level and market evidence overriding that generic prior: the market-implied win probability for ATL (d5) has drifted down from a season median of 0.635 to a terminal reading of 0.385, BAL shows a statistically robust positive scoring-margin advantage (s7 CI [3.02,12.17] excludes zero), and a late injury/news signal (d7, d8) spiked in the final 48 hours coincident with that price move. No out-of-sample backtest of an ATL-specific home-field edge was run (data insufficient), so I anchor on the market price as the best available point estimate rather than the generic base rate.

Own objection: The market price (d5) could reflect stale or duplicated snapshots (six identical 0.385 reads could be one scrape repeated, not six independent updates), so I may be over-weighting a single data point as if it were a converged consensus. Also, home-field advantage and in-division familiarity (not captured in margin-based differentials d1/d2, which are noisy with sd~15-16 points and only weak/no autocorrelation for d1) could push the true probability closer to 45-48% rather than 38.5%, especially if BAL's margin advantage (s7) is driven by a few blowout games rather than consistent week-to-week superiority.

Market Positioning Analyst
39% · confidence 50%

The market-implied probability of an Atlanta win is already converged at ~38.5% (d2, d4 both print 0.385 as of 2026-10-11, the day before kickoff), down from a mid-week reading near 46.5-47% (d3, 2026-10-07) and up from an even earlier stale 0.28-0.29 read (d1, 2026-10-03). This looks like the Ravens-favored line tightening slightly over the week but settling well below the ~57% generic NFL home-win base rate, meaning the market has already priced in Baltimore as the stronger team on the road. Interest/volume proxies (d7, d8) spiked sharply in the final 72 hours (d8 jumping from 1 to 5), consistent with a late news-driven repricing (e.g., injury report) rather than quiet drift, which argues the move is informationally efficient rather than a mispricing an outside analyst can exploit. There is little residual edge beyond the printed 0.385 — any fundamental case for Atlanta has to clear a market that has already moved toward them over the week and is now trading at elevated volume/crowding right before close.

Own objection: If d1-d4 are not all pure win-probability quotes (e.g., one could be a spread-derived number, another a totals or player-prop market mislabeled as game probability), then my read of 'the market says 38.5% ATL' could be wrong, and the true moneyline-implied probability might differ meaningfully from 0.385. Without a confirmed Kalshi/Vegas moneyline tag on each series, I'm inferring the labeling from co-movement and plausibility, which is a real risk to this entire positioning read.

Causal Skeptic
34% · confidence 30%

Base rate for a home team winning an NFL game is roughly 0.55. The data presented here (d1-d6, s1-s6) is almost entirely null: every statistical test of a proposed signal (conditional probabilities, OLS regression on is_home, regime splits, hypothesis tests) failed to reject the null at p<0.05, and the one effect that is directionally interesting (home-field beta negative) is both statistically insignificant and regime-dependent (sign flips across periods per s4), which is a textbook sign of confounding or non-stationarity rather than a stable causal mechanism. The only input with real information content is the market-implied probability (d7≈0.42, d8≈0.29), which likely encodes injury/line information unavailable to me, but it is a price — not a validated causal signal — and shows extreme autocorrelation suggesting limited fresh information near game time. I update away from the generic 0.55 home-field base rate toward the market's apparent skepticism about Atlanta, landing around 0.33-0.35, while explicitly flagging that none of the causal claims implied by this analysis survive scrutiny for confounding, regime-dependence, or circularity.

Own objection: The market price (d8≈0.29, d7≈0.42) already aggregates injury reports, Vegas lines, weather, and matchup-specific information that this dataset doesn't expose to me; treating it skeptically and reverting toward a generic home-field base rate (0.55) could just be wrong because the market has information I'm deliberately discounting. If I'm overcorrecting toward the base rate out of methodological caution, I'm effectively betting against an efficient market with no edge of my own.

Revisions · Every change of mind pinned to one piece of evidence.
Sports Analyst
37% → 37%

debate skipped: panel unanimous within 0.05

Quantitative Researcher
39% → 39%

debate skipped: panel unanimous within 0.05

Market Positioning Analyst
39% → 39%

debate skipped: panel unanimous within 0.05

Causal Skeptic
34% → 34%

debate skipped: panel unanimous within 0.05

Synthesis · The portfolio manager weighs the seats. Not an average.
Portfolio Manager

Base rate: generic NFL home win rate ~0.55-0.57 (cited, not re-derived). The panel unanimously updates well below this base rate, to 0.34-0.39, anchored almost entirely on a market-implied probability series that has drifted from 0.635 to 0.385 over the week, reinforced by BAL's statistically positive point-differential (CI excludes zero) and a late injury/news-volume spike. Critically, the four 'confirming' market series (d2, d4, d5, d8) are not independent — lag-1 autocorrelation of 0.997 and cross-correlation of 0.97 show this is largely one slow-moving quote sampled multiple times, so I collapse them into a single line of evidence rather than four. Every fundamental causal/statistical test run by the Causal Skeptic (home-field OLS, regime splits, conditional win-rate comparisons) was null or regime-dependent, meaning the panel has essentially no validated mechanism-level evidence beyond the price itself and BAL's margin advantage.\n\nConsensus: 0.36, CI [0.29, 0.43] — slightly below the deterministic pool (0.37) and below the raw market print (0.385), reflecting (a) treating the duplicated market series as one evidence line rather than several, and (b) crediting the Causal Skeptic's best-in-segment calibration and valid point that no causal signal survived testing, which argues for added caution rather than full trust in the price's precision.\n\nTradeability: NOT tradeable as a standalone edge. The committee's consensus (0.36) and the market's own implied price (0.385) differ by only ~2.5 points, well within the stated CI and almost certainly within typical sportsbook vig/spread. No analyst identified a mispricing the committee can exploit independently of the market itself — the market has already moved from 0.635 to 0.385 ahead of this analysis, i.e., it got there first. If a counterparty is offering ATL win probability meaningfully above 0.40-0.42 (e.g., due to stale pricing), a small fade (short ATL / long BAL) would be consistent with this view; absent that gap, no position is justified given high crowding (0.85) and weak statistical quality (0.45) in the underlying signal set.\n\nTop disagreement: Causal Skeptic (0.34) vs. others (0.37-0.39) on how much trust to place in the market price given that it's a price, not a causal signal, and the duplicated-series problem. Resolved by anchoring on the price as the best available point estimate (it's the freshest, most information-dense input and is consistent with a coherent injury-timing story) while shading down from the raw print to account for the duplication and the lack of any independent corroborating causal evidence.

Consensus 37% · interval 29% to 43%

Assumptions

Holding · 17
  • holding
    d8's most recent cluster of readings (all 0.385, dated 2026-10-11) represents the current market-implied probability for ATL winning this specific game.
    Sports Analyst
  • holding
    d1 and d2 are ATL's and BAL's respective 7-game scoring-margin histories; d3/d4 are their corresponding win/loss flags over the same window.
    Sports Analyst
  • holding
    d5/d6 (injuries_out, injuries_questionable) reflect a standard weekly injury-report escalation into game week for one of the two teams; without team attribution I cannot assign directional edge from this series.
    Sports Analyst
  • holding
    No information after 2026-10-11 11:42 UTC is used; final inactives and weather for the 2026-10-12 kickoff are unknown.
    Sports Analyst
  • holding
    d5 represents the time series of the Kalshi/market-implied probability that ATL wins this game (price series, 0-1 scale)
    Quantitative Researcher
  • holding
    d1 and d2 represent recent game-level point-differential (margin) series for ATL and BAL respectively, with d2's higher mean/positive CI indicating BAL has outperformed on scoring margin this season
    Quantitative Researcher
  • holding
    d3/d4/d6 are binary win/loss indicators for ATL (d3,d6 duplicate) and BAL (d4) over the same game sample
    Quantitative Researcher
  • holding
    d7/d8 are daily injury-report or line-movement counts in the days leading into the game, with the sharp rise on 2026-10-10/10-11 reflecting news that moved the market
    Quantitative Researcher
  • holding
    No access to the actual current Vegas spread or starting-QB status beyond what is encoded in d5/d7/d8
    Quantitative Researcher
  • holding
    d2 and d4 represent the same or closely related market-implied probability of an Atlanta win, sampled from different windows/sources, both settling at 0.385 as of the as_of date
    Market Positioning Analyst
  • holding
    d3's decline from ~0.465-0.47 (2026-10-07) to the 0.385 floor by 2026-10-11 reflects a real week-long line move toward Baltimore, not a data artifact
    Market Positioning Analyst
  • holding
    d7/d8's sharp rise in the final days (d8: 1→5) reflects increased market attention/volume or injury-report activity correlated with the probability settling, not an unrelated metric
    Market Positioning Analyst
  • holding
    d1's 2026-10-03 stale value (~0.29) is an earlier, less liquid or less informative quote and should be weighted less than the day-of-game reading
    Market Positioning Analyst
  • holding
    d7 and d8 are market-implied probability series for the ATL-win contract or a closely related contract, not independently verified as causal inputs
    Causal Skeptic
  • holding
    d1-d6 represent team-level historical game indicators/point differentials for ATL and BAL in some rolling window, but exact definitions were not confirmed from the data handles alone
    Causal Skeptic
  • holding
    No injury, QB-status, or weather data were supplied, so any 'home field advantage' claim cannot be causally isolated from team quality, rest, or travel confounders
    Causal Skeptic
  • holding
    Sample sizes (n=22-49) are too small to detect a true home-field effect of the typical NFL magnitude (~2-3 points) with any power
    Causal Skeptic

Simulated trade

The portfolio manager proposed no paper trade. Two independent blockers. (1) Instrument-universe mismatch: the only tradeable instruments in this book (HENRY_HUB, UNG, XLE, VLO, MPC, PSX, CORN, BTC, ETH, WTI) are energy/commodity/crypto tickers with no causal or statistical linkage to an NFL game outcome — there is no sports-outcome contract, correlated proxy, or sponsorship/ownership-linked equity in the catalog that would let ATL-vs-BAL exposure be expressed without fabricating a relationship. (2) Even if a sports-outcome contract existed, the synthesis itself found no exploitable edge: committee consensus (0.36) and the market-implied price (0.385) sit ~2.5pts apart, inside the stated CI [0.29,0.43] and almost certainly inside typical vig, with crowding=0.85 and statistical_quality=0.45 on a signal set that collapses to one duplicated market-price series once autocorrelation (0.997) and cross-correlation (0.97) are accounted for. No analyst produced an independent causal or mechanism-level signal (home-field OLS and regime splits were null) that would justify a position against the market's own price, which already moved from 0.635 to 0.385 ahead of this analysis — the market got there first. Recommendation: no trade. If a counterparty elsewhere is quoting ATL win probability materially above ~0.40-0.42 on a venue that actually lists this market, that stale-quote gap — not anything in this instrument catalog — would be the only legitimate edge, and it is not accessible here.

Forecasts

SeatStagePBaseResolvesOutcomeBrier
Committeefinal37%—2026-10-12No0.138
Sports Analystprior33%39%2026-10-12No0.109
Sports Analystindependent37%39%2026-10-12No0.137
Sports Analystrevised37%39%2026-10-12No0.137
Quantitative Researcherprior42%57%2026-10-12No0.176
Quantitative Researcherindependent39%57%2026-10-12No0.148
Quantitative Researcherrevised39%57%2026-10-12No0.148
Market Positioning Analystprior42%57%2026-10-12No0.176
Market Positioning Analystindependent39%57%2026-10-12No0.152
Market Positioning Analystrevised39%57%2026-10-12No0.152
Causal Skepticprior30%55%2026-10-12No0.090
Causal Skepticindependent34%55%2026-10-12No0.116
Causal Skepticrevised34%55%2026-10-12No0.116

Reasoning graph

Every observation, test, claim, objection and forecast, as a graph
observationmemorytestassumptionclaimcounterargumentopinionforecasttrade
observationKXNFLGAME-26OCT11BALATL-ATL.implied…claim · observation · 70%Current market-implied probability …opinionSports Analysttestregime_split: full-sample corr=-0.1…claim · observation · 75%BAL has outperformed ATL over the l…observationNFL-BAL.win [level]testinfluence: corr=-0.19503251595385923claim · inference · 60%ATL's margin series is highly volat…counterargumentTwo consecutive +21 results could r…claim · model · 40%My fair-value estimate for ATL win …observationNFL-BAL.is_home [level]claim · uncertainty · 30%The injury-report series (d5, d6) s…observationNFL-BAL.margin [level]claim · observation · 75%The market-implied probability of a…testconditional_probability: P(outcome|…opinionQuantitative Researchertestdescribe: mean=0.2859183673469388claim · inference · 55%BAL has outperformed on point-diffe…testregression: beta[is_home]=-5.829090…testhypothesis_test: mean(on) − mean(of…claim · model · 60%Margin strongly predicts win probab…testconditional_probability: P(outcome|…observationNFL-ATL.kalshi_win_prob [level]claim · inference · 40%A late-breaking news/injury signal …claim · forecast · 50%Given the market price and point-di…observationNFL-ATL.is_home [level]claim · observation · 55%The market-implied probability of a…opinionMarket Positioning AnalystobservationNFL-ATL.margin [level]claim · inference · 45%The line moved toward Baltimore (aw…counterargumentd3's series identity/meaning relati…claim · observation · 60%Betting/market attention (volume or…claim · inference · 50%Given the late-stage volume surge c…claim · model · 50%Atlanta's market-implied win probab…claim · forecast · 50%Forecast: the Kalshi contract KXNFL…testconditional_probability: P(outcome|…claim · observation · 85%No tested statistical relationship …testregression: beta[is_home]=-5.829090…testconditional_probability: P(outcome|…testhypothesis_test: mean(on) − mean(of…opinionCausal Skepticclaim · inference · 50%The regression (s2) sign for home-f…testinfluence: corr=-0.19503251595385923counterargumentStable sign under leave-one-out (s3…testregime_split: full-sample corr=-0.1…claim · inference · 70%The relationship used to justify an…testdescribe: mean=0.2859183673469388claim · observation · 60%The market-implied probability seri…testdescribe: mean=0.4185169491525424counterargumentd7 and d8 disagree (0.42 vs 0.29), …observationNFL-ATL.win [level]claim · uncertainty · 50%Selection bias: this specific ATL-B…forecastP=0.37 Will the Atlanta Falcons bea…
Click a node. Every conclusion traces back to observations and tests.